| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Robert Rauker CEO | LSE Exchange | GB00BD3B8Z11 ISIN |
| United Kingdom Country | 35 Employees | - Last Dividend | - Last Split | - IPO Date |
Belluscura plc is a pioneering company specializing in the development and commercialization of oxygen-related medical device products primarily targeting users in the United States. Since its establishment in 2015, with its headquarters set in London, the United Kingdom, Belluscura has been at the forefront of innovation in the field of portable oxygen concentrators. The company's mission is geared towards improving the quality of life for people requiring oxygen therapy by offering advanced, lightweight, and modular solutions that ensure users lead an active life with fewer constraints.
The X-PLOR portable oxygen concentrator stands out as a signature product of Belluscura plc. Designed with versatility and user mobility in mind, this device aims to provide users with a reliable source of oxygen while on the move. Its modular nature allows for easy customization to accommodate the varying needs of oxygen therapy patients, promoting enhanced freedom and an active lifestyle.
As another innovative solution, the DISCOV-R portable oxygen concentrator complements Belluscura's product lineup by offering a more advanced, yet still highly transportable, option for oxygen therapy. Catering to a broad range of oxygen needs, this device integrates cutting-edge technology to ensure efficient and effective oxygen delivery, supporting improved patient outcomes.
Belluscura extends its product range by offering a variety of accessories compatible with both the X-PLOR and DISCOV-R oxygen concentrators. These accessories are designed to enhance the user experience, ensuring that the devices meet the specific needs and preferences of each individual. From carrying bags that facilitate ease of movement to batteries that extend the usage time on the go, Belluscura ensures that its customers have everything they need for uninterrupted oxygen therapy.